Ullrich disease
| Ullrich disease | |
|---|---|
| Synonyms | Ullrich congenital muscular dystrophy |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Muscle weakness, joint hypermobility, contractures, scoliosis |
| Complications | N/A |
| Onset | Congenital |
| Duration | Chronic |
| Types | N/A |
| Causes | Mutations in COL6A1, COL6A2, or COL6A3 genes |
| Risks | Genetic inheritance |
| Diagnosis | Genetic testing, muscle biopsy, clinical evaluation |
| Differential diagnosis | Bethlem myopathy, Merosin-deficient congenital muscular dystrophy |
| Prevention | N/A |
| Treatment | Physical therapy, orthopedic interventions, respiratory support |
| Medication | N/A |
| Prognosis | Variable, depends on severity |
| Frequency | Rare |
| Deaths | N/A |
Ullrich Disease
Ullrich disease, also known as Ullrich congenital muscular dystrophy, is a rare genetic disorder characterized by muscle weakness and joint abnormalities. It is part of a group of conditions known as congenital muscular dystrophies.
Ullrich disease - overview[edit]
Ullrich disease is caused by mutations in the genes responsible for producing collagen VI, a protein crucial for the structural integrity of muscle tissue. The condition is named after Otto Ullrich, a German neurologist who first described it in the 1930s.
Symptoms[edit]
The symptoms of Ullrich disease can vary in severity but typically include:
- Muscle Weakness: Generalized muscle weakness is present from birth or early infancy.
- Joint Laxity: Hyperlaxity of distal joints, such as fingers and wrists, is common.
- Contractures: Tightness and contractures of proximal joints, such as elbows and knees, develop over time.
- Respiratory Issues: Some individuals may experience respiratory difficulties due to muscle weakness.
- Scoliosis: Curvature of the spine may occur in some patients.
Genetics[edit]
Ullrich disease is primarily caused by mutations in the COL6A1, COL6A2, or COL6A3 genes. These genes encode the alpha chains of collagen VI, a protein that forms a network around muscle fibers.
- Inheritance Pattern
The disease can be inherited in an autosomal dominant or autosomal recessive manner, depending on the specific genetic mutation involved.
Diagnosis[edit]
Diagnosis of Ullrich disease involves a combination of clinical evaluation, genetic testing, and muscle biopsy. Genetic testing can confirm mutations in the collagen VI genes.
Treatment[edit]
There is currently no cure for Ullrich disease, but treatment focuses on managing symptoms and improving quality of life. This may include:
- Physical Therapy: To maintain muscle strength and flexibility.
- Orthopedic Interventions: Such as braces or surgery to manage joint contractures and scoliosis.
- Respiratory Support: In cases of respiratory muscle weakness.
Prognosis[edit]
The prognosis for individuals with Ullrich disease varies. Some may experience a stable course with mild symptoms, while others may have more severe progression leading to significant disability.
Research[edit]
Ongoing research is focused on understanding the molecular mechanisms of Ullrich disease and developing potential therapies, including gene therapy and protein replacement strategies.
See Also[edit]
References[edit]
- Ullrich, O. (1930). "On a congenital, atonic-sclerotic muscular dystrophy." *Journal of Neurology*. - Lampe, A. K., & Bushby, K. M. (2005). "Collagen VI related muscle disorders." *Journal of Medical Genetics*.
NIH genetic and rare disease info[edit]
Ullrich disease is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Ullrich disease
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian